Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Share price currently up 33% around 80 cents. I think I need $3 to get my money back.
Wouldn't be confident of that happening they have proven product in accustem and look at the c**t they have made of it
If this latest exploit provides a cure/treatment of Alzheimer’s then you might get your £10 SP.
Does anyone know who the major holders of this stock are and their average? Gabriele Cerrone held 66m at end of last year which makes him by far the biggest. No idea how much he paid for most of them and how much were freebies as part of renumeration.
I wrote off the majority of my position a while ago just keeping a few for a miracle, need about £10!
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for intranasal foralumab to be studied in Alzheimer's disease. Foralumab could be a potentially groundbreaking treatment for Alzheimer’s disease, given it targets the disease’s underlying pathology by addressing the resulting neuroinflammation caused by the accumulation of toxic proteins in the brain.
Thanks, yes that is what I make it, but when did it suddenly change from 1:1?
Sorry one to twenty I had 14000 of these load of crap now I have 700 .
They would need to launch at some price to make up for this pathetic s**t show they are messing up
Accustem split was 20 to one
Or rather 1:6
The answer to your question is no I can`t. But the split was 6:1.
Please can anyone point me in the direction of the Accustem news release where it explains the share split? I understand that TILS split 2 to 1, but then my Accustem seem to be 10 to 1, I have only ever read that it was supposed to be a 1:1, but I only have a 10th of what I was expecting? Thanks
1000 days tomorrow if my counting is correct!
1000 days tomorrow and no Nasdaq uplisting, and not even sure if everyone has been issued their shares yet.
1000 days waiting for something decent from accustem. How’s that for a measurable portion of your life?
Yay, another opportunity to run for the hills
TLSA has again received a "deficiency notice" from NASDAQ, and has until Jan 16th 2024 to bring the share price up to a $1 bid or better for 10 consecutive days.
Https://finance.yahoo.com/news/accustem-sciences-inc-emeritusdx-announce-110000007.html
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
LONDON and PHOENIX, July 17, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, and EmeritusDX, a rapidly growing cancer diagnostics and information company, today announced the execution of an agreement wherein both companies will jointly manage scientific operations and R&D for AccuStem’s product portfolio.
Initial plans as part of the collaboration will be to immediately focus on furthering the validation of AccuStem’s core offering, StemPrintER, for patients with breast cancer.
Story continues etc
Does anyone have contact within Tiziana life sciences would appreciate if you can ask for an update there's people scaremongering know stocktwits about dilution and delisting. We're we not expectation data results?
Jimmy G, false alarm, pit lane;)
Hopefully next time but tough to hold the gains at the moment in these markets for any stock.
Just found this
https://t.co/PMX1no5Yg4
Rockz
Gentmen start your engines.
We seamed to have stalled and going to have to start from the pit lane or at the back of the grid
Am I to believe some people still don’t have their shares as well?
Hilarious
Accustem price gone up but TILS share price the same!!!!!
Accustem Sciences (ACUT)
$1.785 +0.65 (+57.27%)
Volume: 50,314
JUN 28, 2023
Gentlemen, start your engines;)